EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSDLEG00000006272
Gene Symbol: ERBB3
3 Cross references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSDLEG00000011065
Gene Symbol: ERBB4
1 Cross references
320 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSDLEG00000009792
Gene Symbol: ESR1
3 Cross references
212 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSDLEG00000012898
Gene Symbol: ESR2
3 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSDLEG00000002929
Gene Symbol: ESRRG
3 Cross references
206 Possible Orthologues:

Exportin 1

Ensembl ID : ENSDLEG00000014180
Gene Symbol: XPO1
1 Cross references
292 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSDLEG00000016328
Gene Symbol: FDPS
3 Cross references
265 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSDLEG00000000157
Gene Symbol: FDFT1
3 Cross references
218 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSDLEG00000021430
Gene Symbol: FNTA
3 Cross references
222 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSDLEG00000014349
Gene Symbol: FAAH
3 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSDLEG00000009032
Gene Symbol: FAP
1 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSDLEG00000018525
Gene Symbol: FGF2
3 Cross references
117 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).